The role of newly cloned genes related to chromosome translocation on hematological differentiation and proliferation.
The role of newly cloned genes related to chromosome translocation on hematological differentiation and proliferation.
批准号:
05454337
负责人:
UEDA Ryuzo
金额:
$4.35万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995
中文摘要
染色体易位在造血系统恶性肿瘤的发生中起重要作用。11 q13区域的研究为套细胞淋巴瘤的发病机制提供了新的线索,而11 q23区域的易位在各种类型的造血系统恶性肿瘤中反复出现。对于11 q13区域,我们通过对PRAD 1基因转录本和突变易位病例的断裂点区域的分析,证实了BCL-1与PRAD 1/cyclin D1基因的同源性。最近,我们生产了一种单克隆抗体,5D4,对PRAD 1/细胞周期蛋白D1的产品,并证明了特定的阳性核染色与套细胞淋巴瘤(MCL)。根据334例血液病患者的免疫组化资料, 关于我们 我们从11 q23区域克隆了两个基因,分别命名为MLL和PCK/P54基因。关于MLL基因,其编码与三胸果蝇同源的3969个氨基酸的多肽,包含由三个AT-钩基序和两个多锌指结构域组成的两个推定的DNA结合基序。急性白血病11 q23易位的断裂点几乎都位于MLL基因的簇区。我们建立了逆转录-聚合酶链反应(RT-PCR)。敏感性研究表明,在10^4至10^5个细胞中可以检测到具有嵌合mRNA的单个克隆。RUT-PER方法为11 q23易位白血病的诊断和治疗反应的监测提供了一种快速、准确、敏感的方法。我们在实验室培育了MLL转基因小鼠,并对其进行了一年半以上的观察。到目前为止,没有观察到荷瘤小鼠。少
英文摘要
Chromosome translocation has been demonstrated to play an important role in the genesis of hematopoietic malignancies. We focused the translocation involving the chromosome 11 band q13 and q23.Recent studies of 11q13 region have shed light on the pathogenesis of mantle cell lymphoma and the translocation on region 11q23 has been recurrently observed in various types of hematopoietic malignancies. Such as malignant lymphoma, acute promyelocytic leukemia, infantile leukemia and secondary leukemia occurring after chemotherapy.Regarding 11q13 region, we proved the identity between BCL-1 and the PRAD1/cyclin D1 gene based on our analyzes of the PRAD1 transcripts and the breakpoint region of the variant translocation case. Recently, we produced a monoclonal antibody, 5D4, against the PRAD1/cyclin D1 product and demonstrated specific positive nuclear staining to be associated with mantle cell lymphoma (MCL). According to the data of immunostaining obtained from 334 cases of hematological diso … More rders including 39 cases of MCL,the MCL showed the poorest prognosis among them.We cloned and characterize the two genes from the 11q23 region, and named MLL and PCK/P54 genes, respectively. Regarding MLL gene, which encodes a 3969 amino acid polypeptide homologous to Drosophila trithorax, containing two putative DNA-binding motifs consisting of three AT-hook motifs and two multiple zinc finger domains. Almost all the breakpoints in acute leukemia with 11q23 translocations lie in a cluster region on the MLL gene. We established the reverse trascriptase-polymerase chain reaction (RT-PCR). Sensitivity studies showed that a single clone with cheimeric mRNA in 10^4 to 10^5 cells could be detected. This RUT-PER method provide a rapid, accurate, and sensitive tool for diagnosing leukemia wtih 11q23 translocation and for monitoring response to therapy in these patients.Recent our analyzes of function of MLL gene show the data thate the N-terminal portion of this gene, may play an important role on tumorigeneses and differentiation. Furthermore we produced the MLL transgenic mice in our laboratory, we have observed them more than one and half year. No tumor bearing mouse was observed, so far. Less
期刊论文(180)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kagami,Y.: "Novel interleukin-2 dependent T-cell line derived from adult T-cell leukemia not associated with human T-cell leukemia virus type 1." Jpn. J. Cancer Res.84. 532-537 (1993)
Kagami,Y.:“源自成人 T 细胞白血病的新型白细胞介素 2 依赖性 T 细胞系,与人类 T 细胞白血病病毒 1 型无关。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Iida,S.: "MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13." Oncogene. 8. 3085-3092 (1993)
Iida,S.:“参与 t(9;11) 白血病的 9p22 上的 MLLT3 基因编码与 19p13 上的 MLLT1 同源的富含丝氨酸/脯氨酸的蛋白质。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Namikawa,R.: "Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice." Blood. 82. 2526-2536 (1993)
Namikawa,R.:“SCID-hu 小鼠的人类骨髓环境中人类髓系白血病的生长。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Iida,S.: "Molecular cloning of 19p13 breakpoint region in intanfile leukemia with t(11;19)(q23;p13)translocation." Jpn.J.Cancer Re.84. 532-537 (1993)
Iida,S.:“具有 t(11;19)(q23;p13) 易位的 intanfile 白血病 19p13 断点区域的分子克隆。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yatabe,Y.: "Clinicopahologic Study of PRAD1/cyclin d1 overexpressing lymphoma with special reference to mantle cell lymphoma,a distinct molecular pathologic entity." Amer. J. Surg. Pathol.(in press).
Yatabe,Y.:“PRAD1/cyclin d1 过表达淋巴瘤的临床病理学研究,特别是套细胞淋巴瘤,这是一种独特的分子病理实体。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 66 条
Development of comprehensive immunotherapy by defuccosylated antibody
-
批准号:22300333
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.15万
-
财政年份:2010
-
负责人:UEDA Ryuzo
-
依托单位:
Development of novel treatment strategy against Hodgkin lymphoma based on the immunopathogenesis
-
批准号:19390266
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.32万
-
财政年份:2007
-
负责人:UEDA Ryuzo
-
依托单位:
The scientific clinical study of antibody therapy
-
批准号:17016065
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$133.82万
-
财政年份:2005
-
负责人:UEDA Ryuzo
-
依托单位:
Molecular-based study for the development of monoclonal antibody therapy in chemokine receptors, CCR4 and CXCR3
-
批准号:16390280
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.36万
-
财政年份:2004
-
负责人:UEDA Ryuzo
-
依托单位:
New therapeutic strategies for treatment of cancer based on basic research
-
批准号:16062101
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$11.84万
-
财政年份:2004
-
负责人:UEDA Ryuzo
-
依托单位:
Development of the optimal therapies based on molecular genetics of multiple myeloma
-
批准号:12470202
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.74万
-
财政年份:2000
-
负责人:UEDA Ryuzo
-
依托单位:
Research on Faint Ground Fault Detection in Power Distribution Line
-
批准号:06650473
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1994
-
负责人:UEDA Ryuzo
-
依托单位:
海外基金